)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
BioPorto (BIOPOR) investor relations material
BioPorto Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status Update summary6 Nov, 2025
Strategic focus and market opportunity
Launched a three-year strategy to drive adoption and usage of kidney health biomarkers, focusing on acute kidney injury (AKI) and expanding into new patient segments and clinical settings.
Ambition to become cashflow positive in H2 2027 and reach DKK 150–200 million in revenue by 2028, with an EBITDA margin target of at least 15%.
FDA approval for pediatric use achieved; adult market entry targeted for 2027 following ongoing studies and pre-submission dialogue with the FDA.
Anticipation of updated clinical guidelines in 2026 to support broader market access and adoption.
Market potential estimated at DKK 700 million, with a focus on intensive care AKI cases and expansion through partnerships.
Commercial execution and sales development
US hospital adoption is increasing, aiming for over 60 active hospitals by 2026 and 100+ globally by 2027, supported by research use and clinical validation.
Commercial strategy in Europe targets key markets, leveraging US experience and aiming for EU IVDR certification in 2027.
Sales process includes hospital validation, staff training, and demonstrating health economic benefits.
US RUO sales grew 20% in Q3 (27% currency-adjusted), with a 24% rolling 12-month growth, while rest of world sales are volatile.
Strategic partnerships with instrument manufacturers are key to accelerating product adoption in laboratories.
Financial performance and guidance
Q3 revenue was DKK 10.4 million, up 7% (10% currency-adjusted); adjusted EBITDA loss was DKK 16.8 million, a 14% improvement.
2025 revenue guidance revised to DKK 40–45 million; EBITDA loss guidance unchanged at DKK 75–80 million.
Funding need of DKK 60–70 million identified to reach cashflow positivity, with options including equity, loans, and potential divestment of the antibody business.
Management expects to announce funding process and timeline soon; both CEO and CFO intend to participate in any equity raise.
Updated aspirations replace previous targets, extending the timeline for cash flow positivity and revenue milestones.
Adult study: Impact of FDA pre-submission?
Drivers for US RUO hospital growth to 60 by 2026?
Rationale for antibody business divestment option?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next BioPorto earnings date
Q3 202519 Nov, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
BioPorto A/S is a global biotech company that specializes in the development and manufacturing of in-vitro diagnostic tests and antibodies for both research and clinical applications. The company's diagnostics products are primarily based on a patented proprietary technology platform called MoAb®. The Company's products are used in research, including preclinical studies and clinical trials, as well as in diagnosis procedures to detect infectious diseases, cancer, autoimmune disorders and other diseases. BioPorto A/S is based in Hellerup, Denmark.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage